Traws Pharma, Inc. (TRAW)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch TRAW
See up to 3 months of TRAW. The 7-day demo opens the 1M and 3M ranges and puts TRAW on your watchlist.
Start 7-day demoLatest TRAW insider trades
About Traws Pharma, Inc. (TRAW)
The SEC lists Traws Pharma, Inc. under CIK 0001130598, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
TRAW Form 4 activity by transaction type, last 90 days
No Form 4 activity for TRAW in the last 90 days.
TRAW insider transactions (Form 4)
4545 Form 4 filings on record, the earliest from Apr 2, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Charles David Pauza - Officer | Grant or award | Stock Option (right to buy) | 97,000 | $0.00 | - | |
| Werner Cautreels | Grant or award | Stock Option (right to buy) | 14,150 | $0.00 | - | |
| Nikolay Savchuk - Officer | Grant or award | Stock Option (right to buy) | 93,000 | $0.00 | - | |
| Jack E. Stover | Grant or award | Stock Option (right to buy) | 14,150 | $0.00 | - | |
| Iain D. Dukes - Officer | Grant or award | Stock Option (right to buy) | 274,000 | $0.00 | - | |
| Robert Redfield - Officer | Grant or award | Stock Option (right to buy) | 84,000 | $0.00 | - | |
 Charles Nolan Parker - Officer | Grant or award | Stock Option (right to buy) | 90,000 | $0.00 | - | |
| Mary Teresa Shoemaker | Grant or award | Stock Option (right to buy) | 14,150 | $0.00 | - | |
| Trafford Clarke | Grant or award | Stock Option (right to buy) | 14,150 | $0.00 | - | |
| John Harold Leaman | Grant or award | Stock Option (right to buy) | 14,150 | $0.00 | - | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market purchase | Common Stock | 597,729 | $1.67 | $998K | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market purchase | Series A Warrants (right to buy) | 597,729 | - footnote F1 | - | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market purchase | Series B Warrants (right to buy) | 597,729 | - footnote F1 | - | |
| ORBIMED ADVISORS LLC - 10% Owner | Open-market purchase | Series C Warrants (right to buy) | 1,793,187 | - footnote F1 | - | |
| ||||||
| Charles Nolan Parker - Officer | Grant or award | Stock Option (right to buy) | 104,544 | $0.00 | - | |
| Charles Nolan Parker - Officer | Grant or award | Common Stock | 15,393 footnote F1 | $0.00 | - | |
| Charles Nolan Parker - Officer | Grant or award | Stock Option (right to buy) | 32,406 | $0.00 | - | |
| Charles Nolan Parker - Officer | Grant or award | Stock Option (right to buy) | 61,571 | $0.00 | - | |
| ||||||
| Trafford Clarke | Grant or award | Stock Option (right to buy) | 33,435 | $0.00 | - | |
| Werner Cautreels | Grant or award | Stock Option (right to buy) | 31,258 | $0.00 | - | |
| John Harold Leaman | Grant or award | Stock Option (right to buy) | 33,435 | $0.00 | - | |
| Iain D. Dukes - Officer | Grant or award | Stock Option (right to buy) | 231,336 | $0.00 | - | |
| Charles David Pauza - Officer | Grant or award | Stock Option (right to buy) | 118,367 | $0.00 | - | |
| Nikolay Savchuk - Officer | Grant or award | Stock Option (right to buy) | 96,899 | $0.00 | - | |
| Jack E. Stover | Grant or award | Stock Option (right to buy) | 33,435 | $0.00 | - | |
| Robert Redfield - Officer | Grant or award | Stock Option (right to buy) | 108,854 | $0.00 | - | |
| Mary Teresa Shoemaker | Grant or award | Stock Option (right to buy) | 33,435 | $0.00 | - | |
| Robert Redfield - Officer | Grant or award | Common Stock | 16,419 footnote F1 | $0.00 | - | |
| Robert Redfield - Officer | Grant or award | Stock Option (right to purchase) | 65,676 | $0.00 | - | |
| ||||||
| Charles David Pauza - Officer | Grant or award | Common Stock | 18,471 footnote F1 | $0.00 | - | |
| Charles David Pauza - Officer | Grant or award | Stock Option (right to purchase) | 73,886 | $0.00 | - | |
| ||||||
| Nikolay Savchuk - Officer | Grant or award | Common Stock | 16,419 footnote F1 | $0.00 | - | |
| Nikolay Savchuk - Officer | Grant or award | Stock Option (right to purchase) | 65,676 | $0.00 | - | |
| ||||||
| Trafford Clarke | Grant or award | Common Stock | 6,157 footnote F1 | $0.00 | - | |
| Trafford Clarke | Grant or award | Stock Option (right to purchase) | 24,629 | $0.00 | - | |
| ||||||
| Mary Teresa Shoemaker | Grant or award | Common Stock | 6,157 footnote F1 | $0.00 | - | |
| Mary Teresa Shoemaker | Grant or award | Stock Option (right to purchase) | 24,629 | $0.00 | - | |
| ||||||
| Iain D. Dukes - Officer | Grant or award | Common Stock | 36,943 footnote F1 | $0.00 | - | |
| Iain D. Dukes - Officer | Grant or award | Stock Option (right to purchase) | 147,771 | $0.00 | - | |
| ||||||
| John Harold Leaman | Grant or award | Common Stock | 4,058 footnote F1 | $0.00 | - | |
| John Harold Leaman | Grant or award | Stock Option (right to purchase) | 16,234 | $0.00 | - | |
| ||||||
| Werner Cautreels | Grant or award | Common Stock | 4,874 footnote F1 | $0.00 | - | |
| Werner Cautreels | Grant or award | Stock Option (right to purchase) | 19,496 | $0.00 | - | |
| ||||||
| Jack E. Stover | Grant or award | Common Stock | 6,157 footnote F1 | $0.00 | - | |
| Jack E. Stover | Grant or award | Stock Option (right to purchase) | 24,629 | $0.00 | - | |
| ||||||
Item 2.02, 7.01, 9.01
Item 3.01
Item 8.01, 9.01
Item 5.02, 5.07, 9.01
TRAW insider trading FAQ
What is the latest insider trade for TRAW?
Traws Pharma, Inc. (TRAW) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-07-16. The full record for TRAW runs to 45 Form 4 filings, the earliest from 2025-04-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying TRAW stock?
No insider purchases of TRAW were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling TRAW stock?
No insider sales of TRAW were filed in the last 90 days.
Where can I see TRAW SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects TRAW Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Charles David Pauza view on EDGAR
- - Werner Cautreels view on EDGAR
- - Nikolay Savchuk view on EDGAR
- - Jack E. Stover view on EDGAR
- - Iain D. Dukes view on EDGAR
- - Robert Redfield view on EDGAR
- - Charles Nolan Parker view on EDGAR
- - Mary Teresa Shoemaker view on EDGAR
- - Trafford Clarke view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where TRAW's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow TRAW with a 7-day demo
- TRAW on your watchlist
- Every TRAW Form 4 filing on record
- Up to 3 months of TRAW price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
